Motoneuron survival is promoted by specific exercise in a mouse model of amyotrophic lateral sclerosis

Journal of Physiology

Volumn 587, Issue 14, 2009, Pages 3561-3572

  Deforges, Séverine ^a   Branchu, Julien ^a   Biondi, Olivier ^a   Grondard, Clément ^a   Pariset, Claude ^a   Lécolle, Sylvie ^a   Lopes, Philippe ^a,b   Vidal, Pierre Paul ^a   Chanoine, Christophe ^a   Charbonnier, Frédéric ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITÉ D EVRY VAL D ESSONNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTATION; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL POPULATION; CELL SURVIVAL; CONTROLLED STUDY; EXERCISE; FORCED SWIMMING TEST; LIFESPAN; MALE; MOTONEURON; MOTOR PERFORMANCE; MOTOR UNIT; MOUSE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; PHENOTYPE; PRIORITY JOURNAL; TREADMILL EXERCISE; ANIMAL BEHAVIOR; ANIMAL CELL; HISTOPATHOLOGY; KINESIOTHERAPY; MOUSE MODEL; MUSCLE TWITCH; RUNNING; SWIMMING; THERAPY EFFECT;

ACTION POTENTIALS; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CELL SURVIVAL; DISEASE MODELS, ANIMAL; EXERCISE THERAPY; HUMANS; MALE; MICE; MICE, TRANSGENIC; MOTOR NEURONS; PHYSICAL CONDITIONING, ANIMAL; PHYSICAL EXERTION;

EID: 67651099064     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2009.169748     Document Type: Article

References (29)

1. Beaumont E & Gardiner P (2002). Effects of daily spontaneous running on the electrophysiological properties of hindlimb motoneurones in rats. J Physiol 540, 129-138.
2. Biondi O, Grondard C, Lécolle S, Deforges S, Pariset C, Lopes P, Cifuentes-Diaz C, Li H, della Gaspera B, Chanoine C & Charbonnier F (2008). Exercise-induced activation of NMDA receptor promotes motor unit development and survival in a type 2 spinal muscular atrophy model mouse. J Neurosci 28, 953-962.
3. Boillée S, Vande Velde C & Cleveland DW (2006). ALS: A disease of motor neurons and their nonneuronal neighbors. Neuron 52, 39-59.
4. Carri MT, Grignaschi G & Bendotti C (2006). Targets in ALS: Designing mutidrug therapies. Trends Pharmacol Sci 27(5), 267-273.
5. Carro E, Nuñez A, Busiguina S & Torres-Aleman I (2000). Circulating insulin-like growth factor I mediates effects of exercise on the brain. J Neurosci 20, 2926-2933.
6. Carro E, Trejo JL, Busiguina S & Torres-Aleman I (2001). Circulating insulin-like growth factor I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy. J Neurosci 21, 5678-5684.
7. Chi L, Ke Y, Luo C, Li B, Gozal D, Kalyanaraman B & Liu R (2006). Motor neuron degeneration promotes neural progenitor cell proliferation, migration, and neurogenesis in the spinal cords of amyotrophic lateral sclerosis mice. Stem Cells 24, 34-43.
8. Delisle MB & Carpenter S (1984). Neurofibrillary axonal swellings and amyotrophic lateral sclerosis. J Neurol Sci 63, 241-250.
9. Dietrich WD, Atkins CM & Bramlett HM (2009). Protection in animal models of brain and spinal cord injury with mild to moderate hypothermia. J Neurotrauma 26, 301-312.
10. Dobrowolny G, Aucello M, Rizzuto E, Beccafico S, Mammucari C, Bonconpagni S, Belia S, Wannenes F, Nicoletti C, Del Prete Z, Rosenthal N, Molinaro M, Protasi F, Fanò G, Sandri M, & Musarò A (2008). Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab 8, 425-436.
11. Dupuis L, Oudart H, René F, Gonzalez de Aguilar JL & Loeffler JP (2004). Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: Benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci U S A 101, 11159-11164.
12. Fergani A, Oudart H, Gonzalez De Aguilar JL, Fricker B, René F, Hocquette JF, Meininger V, Dupuis L & Loeffler JP (2007). Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis. J Lipid Res 48, 1571-1580.
13. Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, Khan J, Polak MA & Glass JD (2004). Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man. Exp Neurol 185, 232-240.
14. Frey D, Schneider C, Xu L, Borg J, Spooren W & Caroni P (2000). Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci 20, 2534-2542.
15. Ghandour MS, Parkkila AK, Parkkila S, Waheed A & Sly WS (2000). Mitochondrial carbonic anhydrase in the nervous system: Expression in neuronal and glial cells. J Neurochem 75, 2212-2220.
16. Grondard C, Biondi O, Pariset C, Lopes P, Deforges S, Lécolle S, Gaspera BD, Gallien CL, Chanoine C & Charbonnier F (2008). Exercise-induced modulation of calcineurin activity parallels the time course of myofibre transitions. J Cell Physiol 214, 126-135.
17. Hall ED, Oostveen JA & Gurney ME (1998). Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 23, 249-256.
18. Heath PR & Shaw PJ (2002). Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis. Muscle Nerve 26, 438-458.
19. Hegedus J, Putman CT, Tyreman N & Gordon T (2008). Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis. J Physiol 586, 3337-3351.
20. Juan L, Dawei Z & Julie AD (2007). Increased number and differentiation of neural precursor cells in the brainstem of superoxide dismutase 1(G93A) (G1H) transgenic mouse model of amyotrophic lateral sclerosis. Neurol Res 29, 204-209.
21. Kaspar BK, Frost LM, Christian L, Umapathi P & Gage FH (2005). Synergy of insulin-like growth factor-1 and exercise in amyotrophic lateral sclerosis. Ann Neurol, 57, 649-655.
22. Kirkinezos IG, Hernandez D, Bradley WG & Moraes CT (2003). Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Ann Neurol 53, 804-807.
23. Liebetanz D, Hagemann K, von Lewinski F, Kahler E & Paulus W (2004). Extensive exercise is not harmful in amyotrophic lateral sclerosis. Eur J Neurosci 20, 3115-3120.
24. Mahoney DJ, Rodriguez C, Devries M, Yasuda N & Tarnopolsky MA (2004). Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis. Muscle Nerve 29, 656-662.
25. Neusch C, Bähr M & Schneider-Gold C (2007). Glia cells in amyotrophic lateral sclerosis: New clues to understanding an old disease? Muscle Nerve 35, 712-724.
26. Rosen DR (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 364, 362.
27. Shefner JM, Reaume AG, Flood DG, Scott RW, Kowall NW, Ferrante RJ, Siwek DF, Upton-Rice M & Brown RH Jr (1999). Mice lacking cytosolic copper/ zinc superoxide dismutase display a distinctive motor axonopathy. Neurology 53, 1239-1246.
28. Veldink JH, Bar PR, Joosten EA, Otten M, Wokke JH & van den Berg LH (2003). Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscul Disord 13, 737-743.
29. Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH, Takahashi R, Misawa H & Cleveland DW (2008). Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 11, 251-253.